abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to medicine and concerns a composition for treating obesity-related disorders containing an insulinotropic peptide conjugate and a pharmaceutically acceptable carrier wherein the insulinotropic peptide is specified in a group consisting of GLP-1, exendin-3, exendin-4 derivatives. n EFFECT: invention provides higher effectiveness of food intake suppression, prolonged in vivo action. n 17 cl, 4 ex, 5 dwg, 3 tbl |